UCB, a global biopharmaceutical company, today announced three-year data from the BE HEARD trials for BIMZELX® (bimekizumab-bkzx) in adults with moderate-to-severe hidradenitis suppurativa (HS).

Oklo's monster run reflects rising market optimism for small reactors -- and their potential role in powering AI computing. But execution won't come easily.

Research also reveals that Shadow AI, the unsanctioned use of AI tools, is fueling data security risks, giving rise to increased human fallibility as more than a third of organizations (37%) admit to ...

Technology is not what powers a data-first culture, but people, operating models, and disciplined delivery. Most organizations already possess more tools and data than they can effectively utilize.

Yunshang Guanche is a SaaS-based vehicle collaboration and mobile management platform developed independently by Beijing Yunshang Guanche Technology Co., Ltd. It innovatively integrates the scenario ...

Launch of digital twins and virtual patients to accelerate and enhance clinical trials • Integration of AI modules into Exagis, Axiodis' proprietary eCRF solution Leuven, BELGIUM, September 16, ...

XYO launched its own Layer One blockchain to handle massive amounts of data for DePIN, AI, and real-world asset (RWA) ...